Enoxaparin sodium (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Enoxaparin sodium drug offered from Fresenius Kabi USA, LLC. This Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | enoxaparin sodium |
| SUBSTANCE NAME: | ENOXAPARIN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2015-02-20 |
| END MARKETING DATE: | 0000-00-00 |
Enoxaparin sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Enoxaparin sodium from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/3mL) |
| START MARKETING DATE: | 2015-02-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-565_18f764b1-dca2-4d03-9b54-c7a24fb22891 |
| PRODUCT NDC: | 63323-565 |
| APPLICATION NUMBER: | NDA020164 |
Other ENOXAPARIN SODIUM Pharmaceutical Manufacturers / Labelers:
